Cannara Biotech Inc (LOVE) - Cash Flow Conversion Efficiency

Latest as of November 2025: 0.072x

Based on the latest financial reports, Cannara Biotech Inc (LOVE) has a cash flow conversion efficiency ratio of 0.072x as of November 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$7.96 Million ≈ $5.76 Million USD) by net assets (CA$111.21 Million ≈ $80.45 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Cannara Biotech Inc (LOVE) liquidity interval to measure how many days the company can operate on defensive assets alone.

Cannara Biotech Inc - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Cannara Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Cannara Biotech Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cannara Biotech Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Grange Resources Ltd AU:GRR	0.038x
Caisse Régionale du Crédit Agricole Alpes Provence PA:CRAP	0.041x
HYUNDAI FEED Inc KQ:016790	0.015x
Kyeryong Const KO:013580	0.114x
ENIGMATIG LIMITED NYSE MKT:EGG	0.008x
Minaurum Silver Inc. V:MGG	-0.431x
ADC Therapeutics SA NYSE:ADCT	0.137x
RiTdisplay Corp TW:8104	0.022x

Annual Cash Flow Conversion Efficiency for Cannara Biotech Inc (2018–2025)

The table below shows the annual cash flow conversion efficiency of Cannara Biotech Inc from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Cannara Biotech Inc.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-08-31	CA$102.22 Million ≈ $73.95 Million	CA$20.01 Million ≈ $14.48 Million	0.196x	+61.19%
2024-08-31	CA$87.95 Million ≈ $63.62 Million	CA$10.68 Million ≈ $7.73 Million	0.121x	+63.86%
2023-08-31	CA$79.74 Million ≈ $57.69 Million	CA$5.91 Million ≈ $4.28 Million	0.074x	+181.38%
2022-08-31	CA$66.74 Million ≈ $48.28 Million	CA$-6.08 Million ≈ $-4.40 Million	-0.091x	-179.05%
2021-08-31	CA$64.12 Million ≈ $46.38 Million	CA$-2.09 Million ≈ $-1.51 Million	-0.033x	+86.57%
2020-08-31	CA$38.36 Million ≈ $27.75 Million	CA$-9.32 Million ≈ $-6.75 Million	-0.243x	-63.78%
2019-08-31	CA$49.93 Million ≈ $36.12 Million	CA$-7.41 Million ≈ $-5.36 Million	-0.148x	+5.07%
2018-08-31	CA$14.74 Million ≈ $10.66 Million	CA$-2.30 Million ≈ $-1.67 Million	-0.156x	--

About Cannara Biotech Inc

V:LOVE Canada Drug Manufacturers - Specialty & Generic

Market Cap

$126.80 Million

CA$175.28 Million CAD

Market Cap Rank

#18380 Global

#604 in Canada

Share Price

CA$1.83

Change (1 day)

-2.14%

52-Week Range

CA$1.27 - CA$1.98

All Time High

CA$3.05